AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
2min snip
409. Keeping Death at Bay | Dr. Adeel Khan
The Jordan B. Peterson Podcast
Advantages of Epizomal Vector Gene Therapy for Sarcopenia
Epizomal vector gene therapy is non-integrating and does not pose risks to the genome like viruses. It does not require immunosuppressants and can be removed with tetracycline if needed. The therapy lasts one and a half to two years and can be repeated, unlike viral vectors. The therapy is being targeted for conditions like sarcopenia, the loss of muscle mass in older adults, which is a significant factor in aging and mortality. The therapy aims to increase levels of a naturally occurring peptide called fallestin to preserve muscle mass and promote anti-aging effects.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode